Engineering Efferocytosis for Bone Regeneration
Macromolecular Bioscience · 2025
DOI: 10.1002/mabi.202500094 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Macromolecular Bioscience, 2025. Verfasst von Jacob Miszuk und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Restorative Sciences & Biomaterials, Boston University Henry M. Goldman School of Dental Medicine, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Bone Regeneration, Phagocytosis, Tissue Engineering. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 141 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDCR NIH HHS, National Institute of Dental and Craniofacial Research.
Abstract (Originalsprache)
Bone is an incredibly robust tissue thanks to its high blood supply, rapid cell turnover, and continuous remodeling. A significant body of research investigates strategies to improve osteogenesis, angiogenesis, and immunomodulation for bone regeneration, facilitated by numerous various therapeutic approaches (e.g. pharmacologics, biomaterials, stem cell therapy, and more). However, a critically understudied but recently emerging area of research lies in the inflammatory cascade and the cleanup of apoptotic cells during repair, aging, and disease. Termed “efferocytosis,” this natural and efficient cleaning up of cells at the end of their lifespan is a crucial step in resolving injury, controlling disease, maintaining homeostasis, and tissue repair. Currently, the primary mechanism(s) driving efferocytosis in most tissue but especially bone, is unknown. Despite this knowledge gap, mounting evidence suggests that impaired efferocytosis plays a significant role in many chronic illnesses and impairs tissue regeneration. Biomaterials‐based interventions are well‐positioned to interrogate mechanisms of efferocytosis due to their ability to provide local support and guide cellular activity not only in combination with but also without additional pharmaceutical aid. This review will highlight the current understanding of efferocytosis in bone and discuss cutting‐edge biomaterials‐based strategies to engineer efferocytosis for improved outcomes in bone regeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Restorative Sciences & Biomaterials, Boston University Henry M. Goldman School of Dental Medicine, Boston, Massachusetts, USA.
- Iowa Institute for Oral Health Research, University of Iowa College of Dentistry, Iowa City, Iowa, USA.
- Department of Oral and Maxillofacial Surgery, University of Iowa College of Dentistry, Iowa City, Iowa, USA.
ORCID-Profile: Hongli Sun
Förderung
- NIDCR NIH HHS
- National Institute of Dental and Craniofacial Research
Zitieren
APA
Miszuk, J., Zhong, L., & Sun, H. (2025). Engineering Efferocytosis for Bone Regeneration. Macromolecular Bioscience. https://doi.org/10.1002/mabi.202500094
Vancouver
Miszuk J, Zhong L, Sun H. Engineering Efferocytosis for Bone Regeneration. Macromolecular Bioscience. 2025. doi:10.1002/mabi.202500094
BibTeX
@article{Miszuk2025,
author = {Miszuk, Jacob and Zhong, Linna and Sun, Hongli},
title = {Engineering Efferocytosis for Bone Regeneration},
journal = {Macromolecular Bioscience},
year = {2025},
doi = {10.1002/mabi.202500094}
}
EUVIMED